Significance of Medicinal Mushrooms in Integrative Oncology: A Narrative Review.
Integrative medicine
complementary medicine
integrative medicine
integrative oncology
medicinal fungi
medicinal mushrooms
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
06
07
2020
accepted:
07
10
2020
entrez:
11
1
2021
pubmed:
12
1
2021
medline:
12
1
2021
Statut:
epublish
Résumé
Medicinal mushrooms are widely used in East Asia for the treatment of various diseases, especially in complementary cancer care. While there is a growing interest in medicinal mushrooms in Western countries and an increasing number of pre-clinical studies indicate distinct anti-cancer and regenerative properties, little is known about their potential relevance for clinical practice. This review aims to provide an overview of the clinical evidence, significance and potential role of medicinal mushrooms in complementary cancer care. Scientific databases for (randomized) controlled clinical trials evaluating whole spectrum formulations of medicinal mushrooms (mushroom powder and mushroom extracts) in cancer patients during and/or after conventional oncological treatment were searched. Eight studies met our inclusion criteria (eight randomized controlled trials, one controlled clinical trial). The medicinal mushrooms investigated were
Identifiants
pubmed: 33424591
doi: 10.3389/fphar.2020.580656
pii: 580656
pmc: PMC7794004
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
580656Informations de copyright
Copyright © 2020 Jeitler, Michalsen, Frings, Hübner, Fischer, Koppold-Liebscher, Murthy and Kessler.
Références
Altern Med Rev. 2002 Jun;7(3):236-9
pubmed: 12126464
Oncotarget. 2018 Jun 26;9(49):29259-29274
pubmed: 30018750
Evid Based Complement Alternat Med. 2018 Apr 22;2018:7271509
pubmed: 29849725
Biomed J. 2014 Nov-Dec;37(6):345-56
pubmed: 25179726
Appl Microbiol Biotechnol. 2002 Nov;60(3):258-74
pubmed: 12436306
PLoS One. 2014 Apr 01;9(4):e93437
pubmed: 24691133
J Ethnopharmacol. 2017 Jul 31;207:47-56
pubmed: 28602756
Hiroshima J Med Sci. 2010 Mar;59(1):1-6
pubmed: 20518254
Evid Based Complement Alternat Med. 2012;2012:809614
pubmed: 22203880
Crit Rev Immunol. 1999;19(1):65-96
pubmed: 9987601
Foods. 2016 Nov 29;5(4):
pubmed: 28231175
Int J Mol Sci. 2017 Sep 08;18(9):
pubmed: 28885559
Cancer Immunol Immunother. 2006 Apr;55(4):404-11
pubmed: 16133112
Food Chem Toxicol. 2018 Sep;119:206-214
pubmed: 29680270
Cell Struct Funct. 2001 Apr;26(2):103-8
pubmed: 11482452
In Vivo. 2011 May-Jun;25(3):355-66
pubmed: 21576408
J Cancer Res Clin Oncol. 2018 Nov;144(11):2177-2186
pubmed: 30043277
Molecules. 2015 Sep 29;20(10):17872-82
pubmed: 26426001
Crit Rev Toxicol. 2005 Jul;35(6):463-582
pubmed: 16422392
BMC Complement Altern Med. 2018 May 9;18(1):152
pubmed: 29743060
Cancer Med. 2015 Feb;4(2):183-200
pubmed: 25449319
Nutr Hosp. 2011 Jan-Feb;26(1):176-86
pubmed: 21519745
Biomed Res Int. 2015;2015:718539
pubmed: 25664323
Cancers (Basel). 2019 Jan 03;11(1):
pubmed: 30609850
Nutr Hosp. 2010 Jul-Aug;25(4):586-96
pubmed: 20694295
Support Care Cancer. 1998 Mar;6(2):101-8
pubmed: 9540167
J Altern Complement Med. 2017 Aug;23(8):648-652
pubmed: 28375640
Sci Rep. 2016 Apr 07;6:24130
pubmed: 27052674
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
Sci Total Environ. 2011 Sep 15;409(20):4297-305
pubmed: 21824641
JAMA. 1998 May 20;279(19):1548-53
pubmed: 9605899
Genome Med. 2016 Apr 20;8(1):42
pubmed: 27098727
Cancer. 1998 Aug 15;83(4):777-82
pubmed: 9708945
Integr Cancer Ther. 2019 Jan-Dec;18:1534735418823266
pubmed: 30791736
Nutr Hosp. 2008 Nov-Dec;23(6):591-8
pubmed: 19132268
Integr Cancer Ther. 2018 Jun;17(2):200-209
pubmed: 29094602
World J Gastroenterol. 2002 Aug;8(4):728-33
pubmed: 12174387
Curr Pharm Des. 2010 Jan;16(1):3-10
pubmed: 20214614
Cancer. 2015 Sep 1;121(17):2942-50
pubmed: 25989179
Jpn J Pharmacol. 2000 Nov;84(3):293-300
pubmed: 11138730
Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129
pubmed: 28603881
Indian J Pharmacol. 2013 May-Jun;45(3):217-22
pubmed: 23833361
Complement Ther Med. 2013 Oct;21(5):460-7
pubmed: 24050580
BMC Complement Altern Med. 2016 Aug 26;16(1):322
pubmed: 27565426
JAMA Oncol. 2017 Apr 1;3(4):524-548
pubmed: 27918777
Food Chem. 2017 Oct 15;233:429-433
pubmed: 28530594
Asian Pac J Cancer Prev. 2013;14(6):3469-72
pubmed: 23886130
Immunol Invest. 2003 Aug;32(3):201-15
pubmed: 12916709
Exp Biol Med (Maywood). 2009 Jan;234(1):53-62
pubmed: 18997106
Int Immunopharmacol. 2010 Jan;10(1):72-8
pubmed: 19811769
Biomed Res Int. 2017;2017:9648496
pubmed: 28890898
Oncotarget. 2018 May 15;9(37):24837-24856
pubmed: 29872510
Int J Urol. 2010 Jun;17(6):548-54
pubmed: 20412340
Vaccine. 2013 Apr 26;31(18):2273-80
pubmed: 23499522
Oncologist. 2002;7(2):120-5
pubmed: 11961195
Int J Med Mushrooms. 2017;19(4):279-317
pubmed: 28605319
ISRN Oncol. 2012;2012:251632
pubmed: 22701186
Int J Gynecol Cancer. 2004 Jul-Aug;14(4):589-94
pubmed: 15304151
Cochrane Database Syst Rev. 2016 Apr 05;4:CD007731
pubmed: 27045603
Molecules. 2011 Sep 15;16(9):7969-79
pubmed: 21921869
Trends Biochem Sci. 2020 Jun;45(6):462-471
pubmed: 32413323
Appl Microbiol Biotechnol. 2011 Mar;89(5):1323-32
pubmed: 21190105